Anticancer immunity through tumor antigen identification & conversion to DNA vaccines
Custom synthetic DNA vaccines elicit efficacious killer T-cell responses that significantly delay tumor progression in lung and ovarian cancer preclinical models PHILADELPHIA -- (Jan. 24,...










